Nguyen D T, Huynh S T, Nguyen H N. Short-term readmission following community-acquired pneumonia: a cross-sectional study[J]. Hosp Pharm, 2022, 57(6):712-720.
[2]
Cillóniz C, Liapikou A, Martin L I, et al. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia[J]. PloS One, 2018, 13(7): e0200504.
[7]
Zhao L H, Chen J, Zhu R X. The relationship between frailty and community-acquired pneumonia in older patients[J]. Aging Clin Exp Res, 2023, 35(2):349-355.
[3]
安 娜.《2022年度国家老龄事业发展公报》发布[J]. 社会与公益, 2023(12):7.
[8]
Furman, Christian D,Leinenbach, A, et al. Pneumonia in older adults[J]. Curr Opin Infect Dis, 2021, 34(2):135-141.
[4]
Laporte L, Hermetet C, Jouan Y, et al. Ten-year trends in intensive care admissions for respiratory infections in the elderly[J]. Ann Intensive Care, 2018, 8(1): 84.
[9]
Metlay J P, Waterer G W, Long A C, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the american thoracic society and infectious diseases society of america[J]. Am J Respir Crit Care Med, 2019, 200(7): e45-e67.
[5]
Mahendra M, Jayaraj B S, Limaye S, et al. Factors influencing severity of community-acquired pneumonia[J]. Lung India, 2018, 35(4):284-289.
[10]
Cillóniz C, Dominedò C, Pericàs J M, et al. Community-acquired pneumonia in critically ill very old patients: a growing problem[J]. Eur Respir Rev, 2020, 29(155):190126.
[6]
Nguyen D T, Huynh S T, Nguyen H N. Short-term readmission following community-acquired pneumonia: a cross-sectional study[J]. Hosp Pharm, 2022, 57(6):712-720.
[11]
Cho S J, Stout H W. Aging and lung disease[J]. Annu Rev Physiol, 2020, 82:433-459.
[7]
Zhao L H, Chen J, Zhu R X. The relationship between frailty and community-acquired pneumonia in older patients[J]. Aging Clin Exp Res, 2023, 35(2):349-355.
[12]
He M, Borlak J. A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence[J]. Immun Ageing, 2023, 20(1):58.
[8]
Furman, Christian D,Leinenbach, A, et al. Pneumonia in older adults[J]. Curr Opin Infect Dis, 2021, 34(2):135-141.
[13]
Makino K, Shimizu R, Goda N, et al. Unbiased, comprehensive analysis of Japanese health checkup data reveals a protective effect of light to moderate alcohol consumption on lung function. Sci Rep, 2021, 11(1):15954.
[9]
Metlay J P, Waterer G W, Long A C, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the american thoracic society and infectious diseases society of america[J]. Am J Respir Crit Care Med, 2019, 200(7): e45-e67.
[14]
Hamazaki N, Masuda T, Kamiya K, et al. Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure[J]. Respirology, 2019, 24(2):154-161.5
[10]
Cillóniz C, Dominedò C, Pericàs J M, et al. Community-acquired pneumonia in critically ill very old patients: a growing problem[J]. Eur Respir Rev, 2020, 29(155):190126.
[15]
Chebib N, Cuvelier C, Malézieux P A, et al. Pneumonia prevention in the elderly patients: the other sides[J]. Aging Clin Exp Res, 2021, 33(4):1091-1100.
[11]
Cho S J, Stout H W. Aging and lung disease[J]. Annu Rev Physiol, 2020, 82:433-459.
[16]
Chen Y, Klein S L, Garibaldi B T, et al. Aging in COVID-19: vulnerability, immunity and intervention[J]. Ageing Res Rev, 2021, 65:101205.
[12]
He M, Borlak J. A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence[J]. Immun Ageing, 2023, 20(1):58.
[17]
Guo R N, Dan Z, Fan Z, et al. Clinical characteristics and pathogen analysis of bronchoalveolar lavage fluid in elderly patients with community-acquired pneumonia[J]. Immun Inflamm Dis, 2023, 11(4):e813.
[13]
Makino K, Shimizu R, Goda N, et al. Unbiased, comprehensive analysis of Japanese health checkup data reveals a protective effect of light to moderate alcohol consumption on lung function. Sci Rep, 2021, 11(1):15954.
[18]
Song Y, Wang X, Lang K, et al. Development and validation of a nomogram for predicting 28-day mortality on admission in elderly patients with severe community-acquired pneumonia[J]. J Inflamm Res, 2022, 15:4149-4158.
[19]
Ryoo N, Pyun J M, Baek M J, et al. Coping with dementia in the middle of the COVID-19 pandemic[J]. J Korean Med Sci, 2020, 35(42): e383.
[20]
Schöll N, Rohde G U. Ambulant erworbene pneumonie beiälteren menschen community-acquired pneumonia in the elderly[J]. Pneumologie, 2019, 73(10):605-616.
[14]
Hamazaki N, Masuda T, Kamiya K, et al. Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure[J]. Respirology, 2019, 24(2):154-161.5
[21]
Li Z J, Zhang H Y, Ren L L, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1): 5026.
[15]
Chebib N, Cuvelier C, Malézieux P A, et al. Pneumonia prevention in the elderly patients: the other sides[J]. Aging Clin Exp Res, 2021, 33(4):1091-1100.
[22]
Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis[J]. J Infect, 2020, 81(2):266-275.
[16]
Chen Y, Klein S L, Garibaldi B T, et al. Aging in COVID-19: vulnerability, immunity and intervention[J]. Ageing Res Rev, 2021, 65:101205.
[23]
Han X, Zhou F, Li H, et al. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia[J].BMC Infect Dis, 2018, 18(1): 192.
[17]
Guo R N, Dan Z, Fan Z, et al. Clinical characteristics and pathogen analysis of bronchoalveolar lavage fluid in elderly patients with community-acquired pneumonia[J]. Immun Inflamm Dis, 2023, 11(4):e813.
[24]
Lin W H, Chiu H C, Chen K F, et al. Molecular detection of respiratory pathogens in community-acquired pneumonia involving adults[J]. J Microbiol Immunol Infect, 2022, 55(5): 829-837.
[18]
Song Y, Wang X, Lang K, et al. Development and validation of a nomogram for predicting 28-day mortality on admission in elderly patients with severe community-acquired pneumonia[J]. J Inflamm Res, 2022, 15:4149-4158.
[25]
Yamasue M, Komiya K, Kinjo T, et al. Rebound mortality rate of Legionella pneumonia in Japan[J]. Respir Investig, 2023, (4):487-489.
[19]
Ryoo N, Pyun J M, Baek M J, et al. Coping with dementia in the middle of the COVID-19 pandemic[J]. J Korean Med Sci, 2020, 35(42): e383.
[26]
Viasus D, Gaia V, Manzur B C, et al. Legionnaires' disease: update on diagnosis and treatment[J]. Infect Dis Ther, 2022, 11(3):973-986.
[20]
Schöll N, Rohde G U. Ambulant erworbene pneumonie beiälteren menschen community-acquired pneumonia in the elderly[J]. Pneumologie, 2019, 73(10):605-616.
[27]
Liu Y N, Zhang Y F, Xu Q, et al. Chinese center for disease control and prevention etiology surveillance study team of acute respiratory infections. infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study[J]. Lancet Microbe, 2023, 4(5):e330-e339.
[21]
Li Z J, Zhang H Y, Ren L L, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1): 5026.
[28]
Costa M I, Cipriano A, Santos F V, et al. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia[J]. Pulmonology,2022, 28(5):358-367.
[22]
Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis[J]. J Infect, 2020, 81(2):266-275.
[23]
Han X, Zhou F, Li H, et al. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia[J].BMC Infect Dis, 2018, 18(1): 192.
[29]
Miellet W R, Veldhuizen J, Nicolaie M A, et al. Influenza-like illness exacerbates pneumococcal carriage in older adults[J]. Clin Infect Dis, 2021, 73(9):e2680-e2689.
[24]
Lin W H, Chiu H C, Chen K F, et al. Molecular detection of respiratory pathogens in community-acquired pneumonia involving adults[J]. J Microbiol Immunol Infect, 2022, 55(5): 829-837.
[30]
Kirtipal N, Bharadwaj S, Kang S G. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses[J]. Infect Genet Evol, 2020, 85:104502.
[31]
Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China[J]. Science, 2020, 368(6491): 638-642.
[25]
Yamasue M, Komiya K, Kinjo T, et al. Rebound mortality rate of Legionella pneumonia in Japan[J]. Respir Investig, 2023, (4):487-489.
[32]
Chen B, Tian E K, He B, et al. Overview of lethal human coronaviruses[J]. Signal Transduct Target Ther, 2020, 5(1): 89.
[26]
Viasus D, Gaia V, Manzur B C, et al. Legionnaires' disease: update on diagnosis and treatment[J]. Infect Dis Ther, 2022, 11(3):973-986.
[33]
Lu Q B, Zhang H Y, Che T L, et al. The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis[J]. BMC Infect Dis, 2021, 21(1): 481.
[27]
Liu Y N, Zhang Y F, Xu Q, et al. Chinese center for disease control and prevention etiology surveillance study team of acute respiratory infections. infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study[J]. Lancet Microbe, 2023, 4(5):e330-e339.
[34]
Azoilay E, Vincent J L, Angus D C, et al. Recovery after critical illness: putting the puzzle together-a consensus of 29[J]. Crit Care, 2017, 21(1): 296.
[28]
Costa M I, Cipriano A, Santos F V, et al. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia[J]. Pulmonology,2022, 28(5):358-367.
[35]
Torres A, Cilloniz C, Niederman M S, et al. Pneumonia[J]. Nat Rev Dis Primers, 2021, 7(1):25.
[29]
Miellet W R, Veldhuizen J, Nicolaie M A, et al. Influenza-like illness exacerbates pneumococcal carriage in older adults[J]. Clin Infect Dis, 2021, 73(9):e2680-e2689.
[36]
Altuna V S, Aliaga V R, Maguiña J L, et al. Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015[J]. Arch Gerontol Geriatr, 2019, 82: 100-105.
[30]
Kirtipal N, Bharadwaj S, Kang S G. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses[J]. Infect Genet Evol, 2020, 85:104502.
[37]
Hespanhol V, Bárbara C. Pneumonia mortality, comorbidities matter?[J].Pulmonology, 2020, 26(3):123-129.
[31]
Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China[J]. Science, 2020, 368(6491): 638-642.
[38]
Kofteridis D P, Giourgouli G, Plataki M N, et al. Community-acquired pneumonia in elderly adults with type 2 diabetes mellitus[J]. J Am Geriatr Soc, 2016, 64(3): 649-651.
[32]
Chen B, Tian E K, He B, et al. Overview of lethal human coronaviruses[J]. Signal Transduct Target Ther, 2020, 5(1): 89.
[39]
Lin C J, Chang Y C, Tsou M T, et al. Factors associated with hospitalization for community-acquired pneumonia in home health care patients in Taiwan[J]. Aging Clin Exp Res, 2020, 32(1): 149-155.
[33]
Lu Q B, Zhang H Y, Che T L, et al. The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis[J]. BMC Infect Dis, 2021, 21(1): 481.
[40]
Yeo H J, Byun K S, Han J, et al. Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: a propensity score matched analysis[J]. Korean J Intern Med, 2019, 34(4): 841-849.
[34]
Azoilay E, Vincent J L, Angus D C, et al. Recovery after critical illness: putting the puzzle together-a consensus of 29[J]. Crit Care, 2017, 21(1): 296.
[41]
Guo Y, Ng N, Hassler S, et al. Frailty trajectories in Chinese older adults: evidence from the china health and retirement longitudinal study[J]. Innov Aging, 2023, 8(1):igad131.
[35]
Torres A, Cilloniz C, Niederman M S, et al. Pneumonia[J]. Nat Rev Dis Primers, 2021, 7(1):25.
[42]
Zhao H, Tu J, She Q, et al. Prognostic significance of frailty in hospitalized elderly patients with community-acquired pneumonia: a retrospective cohort study[J]. BMC Geriatr, 2023, 23(1):308.
[36]
Altuna V S, Aliaga V R, Maguiña J L, et al. Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015[J]. Arch Gerontol Geriatr, 2019, 82: 100-105.
[43]
Niederman M S, Cilloniz C. Aspiration pneumonia[J]. Rev Esp Quimioter, 2022, 35 Suppl 1(Suppl 1):73-77.
[37]
Hespanhol V, Bárbara C. Pneumonia mortality, comorbidities matter?[J].Pulmonology, 2020, 26(3):123-129.
[38]
Kofteridis D P, Giourgouli G, Plataki M N, et al. Community-acquired pneumonia in elderly adults with type 2 diabetes mellitus[J]. J Am Geriatr Soc, 2016, 64(3): 649-651.
[39]
Lin C J, Chang Y C, Tsou M T, et al. Factors associated with hospitalization for community-acquired pneumonia in home health care patients in Taiwan[J]. Aging Clin Exp Res, 2020, 32(1): 149-155.
[40]
Yeo H J, Byun K S, Han J, et al. Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: a propensity score matched analysis[J]. Korean J Intern Med, 2019, 34(4): 841-849.
[41]
Guo Y, Ng N, Hassler S, et al. Frailty trajectories in Chinese older adults: evidence from the china health and retirement longitudinal study[J]. Innov Aging, 2023, 8(1):igad131.
[42]
Zhao H, Tu J, She Q, et al. Prognostic significance of frailty in hospitalized elderly patients with community-acquired pneumonia: a retrospective cohort study[J]. BMC Geriatr, 2023, 23(1):308.
[43]
Niederman M S, Cilloniz C. Aspiration pneumonia[J]. Rev Esp Quimioter, 2022, 35 Suppl 1(Suppl 1):73-77.
2024, Vol. 35 
